ARVINAS, INC. Income (Loss) Attributable to Parent, before Tax
ARVINAS, INC. (ARVN) reported Income (Loss) Attributable to Parent, before Tax of -$64.00 million for the 3-month period ending 2022-09-30, per its 10-Q filed 2022-11-09.
Discontinued › Expense Statement › Operating Expenses
us-gaap:IncomeLossAttributableToParent · last filed 2022-11-09
- ARVINAS, INC. income (loss) attributable to parent, before tax for the quarter ending 2022-09-30 was -$64.00M.
- ARVINAS, INC. income (loss) attributable to parent, before tax for the quarter ending 2022-06-30 was -$66.60M.
- ARVINAS, INC. income (loss) attributable to parent, before tax for the quarter ending 2022-03-31 was -$58.90M.
- ARVINAS, INC. income (loss) attributable to parent, before tax for the quarter ending 2021-09-30 was -$46.80M.
| Period end | Income (Loss) Attributable to Parent, before Tax 3 month | Income (Loss) Attributable to Parent, before Tax 6 month | Income (Loss) Attributable to Parent, before Tax 9 month |
|---|---|---|---|
| 2022-09-30 | -$64.00M 10-Q · filed 2022-11-09 | -$130.60M derived: sum of 2 quarters · filed 2022-11-09 | -$189.50M 10-Q · filed 2022-11-09 |
| 2022-06-30 | -$66.60M 10-Q · filed 2022-08-04 | -$125.50M 10-Q · filed 2022-08-04 | |
| 2022-03-31 | -$58.90M 10-Q · filed 2022-05-05 | ||
| 2021-09-30 | -$46.80M 10-Q · filed 2022-11-09 | -$97.10M derived: sum of 2 quarters · filed 2022-11-09 | -$138.00M 10-Q · filed 2022-11-09 |
| 2021-06-30 | -$50.30M 10-Q · filed 2022-08-04 | -$91.30M 10-Q · filed 2022-08-04 | |
| 2021-03-31 | -$41.00M 10-Q · filed 2022-05-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PUMA BIOTECHNOLOGY, INC. (PBYI) | United States | $0.507B | 15.53 |
| Evolus, Inc. (EOLS) | United States | $0.519B | -13.32 |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | United States | $0.499B | -10.81 |
| CRESCENT BIOPHARMA, INC. (CBIO) | United States | $0.529B | -5.20 |
| Ovid Therapeutics Inc. (OVID) | United States | $0.487B | -14.41 |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B | |
| ASSEMBLY BIOSCIENCES, INC. (ASMB) | United States | $0.481B | -13,053.96 |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 |